| Pathway
|
NURD Chromatin Remodeling
|
|
Prostate Cancer Overview
|
|
Metastatic Colorectal Cancer Overview
|
|
Mechanism of Cetuximab Resistance in Colorectal Cancer
|
|
RARA Signaling Pathway in Acute Myeloid Leukemia (M3)
|
|
FLT3 and KIT Signaling to MLL Pathway in Acute Myeloid Leukemia (M5)
|
|
Block of Apoptosis in Acute Myeloid Leukemia
|
|
Block of Differentiation in Acute Myeloid Leukemia
|
|
Acute Myeloid Leukemia Overview
|
|
Alzheimer's Disease Overview
|
|
IL-6/IGF-1/VEGFA in Multiple Myeloma
|
|
Multiple Myeloma Overview
|
|
T-cell Acute Lymphoblastic Leukemia Overview
|
|
B-cell Chronic Lymphocytic Leukemia Overview
|
|
APP and Glutamate Signaling-Related Neuronal Dysfunction in Alzheimer's Disease
|
|
Follicular Lymphoma Overview
|
|
Cowden Syndrome
|
|
Proteins Involved in Pathogenesis of Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway
|
|
Proteins Involved in Pathogenesis of Breast Cancer Related to IGF1R/Akt Signaling Pathway
|
|
Breast Cancer Related to IGF1R/Akt Signaling Pathway
|
|
Breast Cancer Related to ERBB/VEGFR/Akt Signaling Pathway
|
|
Proteins Involved in Pathogenesis of Breast Cancer Related to ESR1 Signaling Pathway
|
|
ESR1/ERBB-positive Luminal Breast Cancer
|
|
Basal Breast Cancer
|
|
Insulin Influence on Glycogenesis
|
|
Insulin Influence on Protein Synthesis
|
|
Impaired Adiponectin Synthesis in Insulin Resistance
|
|
Clear Cell Ovarian Carcinoma
|
|
Mucinous Ovarian Carcinoma
|
|
High-grade Serous Ovarian Carcinoma
|
|
Endometrioid Ovarian Carcinoma
|
|
Ovarian Cancer Overview
|
|
Low-grade Serous Ovarian Carcinoma
|
|
Type I Endometrial Cancer (Endometrioid Endometrial Cancer)
|
|
Type II Endometrial Cancer (Clear-cell Endometrial Cancer and Papillary Serous Endometrial Cancer)
|
|
Endometrial Cancer Overview
|
|
Melanoma Overview
|
|
Model of T-cell Maturation
|
|
Cancer Overview
|
|
CFTR Up-regulates the Oxidative Stress in Airway Epithelium in Cystic Fibrosis
|
|
Mucin Production in Goblet Airway Epithelial Cells in Cystic Fibrosis
|
|
Smooth Muscle Cell Dysfunction in Pulmonary Arterial Hypertension
|
|
Primary Glioblastoma
|
|
Secondary Glioblastoma
|
|
Glioma Invasion Signaling
|
|
Astrocytoma
|
|
Osteoarthritis Overview
|
|
Steroid-Induced Cataract
|
|
Impairment of EDN, NRG, NRTN, and GDNF/RET Signaling in Hirschsprung Disease
|
|
Growth Factor Signaling in Neuroblastoma
|
|
Neuroblastoma Overview
|
|
Growth Factor Signaling in Pancreatic Cancer
|
|
TGFBR Signaling in Pancreatic Cancer
|
|
Pancreatic Ductal Carcinoma
|
|
Pancreatic Neuroendocrine Tumors
|
|
Impaired Steroidogenesis in Polycystic Ovary Syndrome
|
|
Polycystic Ovary Syndrome Overview
|
|
Growth Factor Signaling in Hepatocellular Carcinoma
|
|
Proteins Involved in Pathogenesis of Hepatocellular Carcinoma
|
|
Hepatocellular Carcinoma Overview
|
|
Synovial Fibroblast Proliferation in Rheumatoid Arthritis
|
|
Mechanism of Skin Fibrosis in Systemic Scleroderma
|
|
Myocardial Remodeling in Myocardial Ischemia
|
|
Role of Scavenger Receptor OLR1 in Inflammation-Related Endothelial Dysfunction in Atherosclerosis
|
|
Nociception-related DRD2 expression targets
|
|
CHRM1 -> IL2 production
|
|
Nociception-related NTSR1 expression targets
|
|
NTRK1/2/3 -> acetylcholine production
|
|
Summarized nociception-related expression targets
|
|
Regulation of calcium flux
|
|
FGFR -> AP-1/CREB/CREBBP/ELK-SRF/MYC signaling
|
|
PDGFR -> AP-1/MYC signaling
|
|
VEGFR -> AP-1/CREB/MYC signaling
|
|
HGFR -> AP-1/CREB/MYC signaling
|
|
ThrombopoietinR -> AP-1/CREB/ELK-SRF/MYC signaling
|
|
EGFR -> AP-1/CREB/ELK-SRF/MYC signaling
|
|
EGFR -> NCOR2 signaling
|
|
FcIgER -> ELK-SRF signaling
|
|
EGFR/ERBB2 -> HIF1A signaling
|
|
EGFR -> AP-1/ATF2 signaling
|
|
EGFR/ERBB2 -> TP53 signaling
|
|
EGFR -> CTNND signaling
|
|
EGFR/ERBB2 -> CTNNB signaling
|
|
ERBB2/3 -> EP300/ETS/ETV/SP1 signaling
|
|
EGFR -> SMAD1 signaling
|
|
EGFR/ERBB -> STAT signaling
|
|
FGFR -> RUNX2 signaling
|
|
KIT -> MITF signaling
|
|
VEGFR -> NFATC signaling
|
|
VEGFR -> ATF/CREB/ELK-SRF signaling
|
|
IGF1R -> ELK-SRF/HIF1A/MYC/SREBF signaling
|
|
InsulinR -> ELK-SRF/SREBF signaling
|
|
GDNF -> HSF1 signaling
|
|
NTRK -> AP-1/CREB/ELK-SRF/MYC/SMAD3/TP53 signaling
|
|
DDR1 -> NF-kB signaling
|
|
UrokinaseR -> ELK-SRF signaling
|
|
FibronectinR -> AP-1/ELK-SRF/SREBF signaling
|
|
IL4R -> ELK-SRF/HMGY signaling
|
|
IL2R -> ELK-SRF/MYC signaling
|
|
ErythropoietinR -> ELK-SRF/FOS signaling
|
|
ThrombopoietinR -> SPI1 signaling
|
|
ThrombopoietinR -> SP1 signaling
|
|
GHR -> ELK-SRF/MYC signaling
|
|
EDG2 -> ELK-SRF signaling
|
|
CholinergicRm -> CREB/ELK-SRF signaling
|
|
DopamineR2 -> AP-1/CREB/ELK-SRF signaling
|
|
NeurotensinR -> ELK-SRF/AP-1/EGR signaling
|
|
VasopressinR1 -> CREB/ELK-SRF/AP-1/EGR signaling
|
|
GRM1/5 -> CREB signaling
|
|
VasopressinR2 -> CREB/ELK-SRF/AP-1/EGR signaling
|
|
ThrombinR -> AP-1/CREB/ELK-SRF/SP1 signaling
|
|
ROS in Angiotensin-Mediated Cardiovascular Remodeling and Hypertrophy
|
|
NGF/FOXO/MYCN/ELK-SRF Expression Targets
|
|
NGF/AP-1/TP53/MYC Expression Targets
|
|
NGF/CREB/CEBPB/MEF2A Expression Targets
|
|
NGF/SMAD3/NF-kB Expression Targets
|
|
Fibronectin Expression Targets
|
|
CD247 Expression Targets
|
|
FCGR3A Expression Targets
|
|
PLAU/ELK-SRF/AP-1 Expression Targets
|
|
IL2 Expression Targets
|
|
IL4 Expression Targets
|
|
Thrombopoietin/SPI1 Expression Targets
|
|
Thrombopoietin/SP1 Expression Targets
|
|
Erythropoietin/ELK-SRF Expression Targets
|
|
GH1-GHR/NF-kB/ELK-SRF/MYC Expression Targets
|
|
PRL-GHR/NF-kB/ELK-SRF/MYC Expression Targets
|
|
CSH1-GHR Expression Targets
|
|
Dopamine/Gi Expression Targets
|
|
Acetylcholine Expression Targets
|
|
AREG/SMAD1 Expression Target
|
|
AREG/STAT Expression Targets
|
|
AREG/AP-1 Expression Targets
|
|
AREG/HIF1A Expression Targets
|
|
BTC/STAT Expression Targets
|
|
BTC/EP300/ETS/ETV/SP1 Expression Targets
|
|
EGF/HIF1A Expression Targets
|
|
EGF/TP53 Expression Targets
|
|
EREG/CTNNB/CTNND Expression Target
|
|
EREG/STAT Expression Targets
|
|
EREG/AP-1/ATF Expression Targets
|
|
EREG/EP300/SP1 Expression Targets
|
|
EREG/HIF1A Expression Target
|
|
HBEGF/STAT Expression Targets
|
|
HBEGF/AP-1/ATF Expression Targets
|
|
HBEGF/EP300/ETS/ETV/SP1 Expression Targets
|
|
HBEGF/HIF1A Expression Targets
|
|
HBEGF/TP53 Expression Targets
|
|
NRG1/Catenin Expression Targets
|
|
NRG1/STAT Expression Targets
|
|
NRG1/AP-1/ATF Expression Targets
|
|
NRG1/EP300/ETS/ETV/SP1 Expression Targets
|
|
NRG1/HIF1A Expression Target
|
|
NRG1/TP53 Expression Target
|
|
TGFA/CTNNB/CTNND Expression Targets
|
|
TGFA/STAT Expression Targets
|
|
TGFA/HIF1A Expression Targets
|
|
TGFA/TP53 Expression Targets
|
|
FGF2/RUNX Expression Targets
|
|
VEGFA/NFATC Expression Targets
|
|
VEGFA/ATF/CREB/ELK-SRF Expression Targets
|
|
VEGFC/ATF Expression Target
|
|
Collagen/NF-kB Expression Targets
|
|
GDNF/HSF1 Expression Targets
|
|
IGF2/HIF1A/MYC Expression Targets
|
|
CTGF/AP-1/CREB/MYC Expression Targets
|
|
CTGF/NCOR2 Expression Target
|
|
PGF/AP-1/CREB/CREBBP/MYC Expression Targets
|
|
Thrombopoietin/AP-1/CREB/CREBBP/MYC Expression Targets
|
|
AREG/CREB/CREBBP Expression Targets
|
|
AREG/FOXO3A Expression Target
|
|
AREG/NCOR2 Expression Targets
|
|
EGF/FOXO3A Expression Targets
|
|
EGF/NCOR2 Expression Target
|
|
EREG/CREB Expression Target
|
|
EREG/FOXO3A Expression Target
|
|
HBEGF/CREB/MYC Expression Targets
|
|
HBEGF/FOXO3A Expression Target
|
|
NRG1/CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
NRG1/FOXO3A Expression Targets
|
|
TGFA/CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
TGFA/FOXO3A Expression Targets
|
|
FGF1/AP-1/CREB/ELK-SRF/MYC Expression Targets
|
|
FGF1/NCOR2 Expression Target
|
|
FGF2/FOXO3A Expression Targets
|
|
FGF2/NCOR2 Expression Targets
|
|
FGF4/AP-1/MYC Expression Targets
|
|
FGF10/AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF10/FOXO3A Expression Target
|
|
CSF1/AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PDGFB/AP-1/CREB/MYC Expression Target
|
|
PDGFC/CREB Expression Target
|
|
PDGFD/AP-1 Expression Targets
|
|
VEGFA/NCOR2 Expression Target
|
|
FIGF/AP-1 Expression Target
|
|
FIGF/NCOR2 Expression Target
|
|
F2 -> AP-1/CREB/ELK-SRF/SP1 Expression Targets
|
|
PLG -> AP-1/CREB/ELK-SRF/SP1 Expression Targets
|
|
Glutamate/Gq Expression Targets
|
|
AVP/Gq -> CREB/ELK-SRF/AP-1/EGR Expression Targets
|
|
NTS Expression Targets
|
|
AVP/Gs -> CREB/ELK-SRF/AP-1/EGR Expression Targets
|
|
FGF2/AP-1/CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
Insulin/ELK-SRF/HIF1A/MYC/SREBF Expression Targets
|
|
EGF/AP-1/ATF Expression Targets
|
|
EGF/CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
EGF/STAT Expression Targets
|
|
HGF/AP-1/CREB/ELK-SRF/MYC Expression Targets
|
|
IGF1/ELK-SRF/HIF1A/MYC/SREBF Expression Targets
|
|
KITLG/AP-1/CREB/CREBBP/MYC Expression Targets
|
|
LPA Expression Targets
|
|
PDGF/AP-1/CREB/CREBBP/MYC Expression Targets
|
|
TGFA/AP-1/ATF Expression Targets
|
|
VEGFA/AP-1/CREBBP/MYC Expression Targets
|
|
AREG/CTNN Expression Targets
|
|
BTC/AP-1/ATF/CREB Expression Targets
|
|
BTC/CTNN Expression Targets
|
|
EGF/CTNN Expression Targets
|
|
FGF1/RUNX Expression Targets
|
|
insulin signaling pathway
|
|
scatter factor-hepatocyte growth factor signaling pathway
|
|
insulin signaling pathway
|
|
altered insulin signaling pathway
|
|
epidermal growth factor/neuregulin signaling pathway
|